Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 19:53 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- NOK 49.06T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | NOK 46B | NOK 130.97 | 2.78% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | NOK 92.6B | NOK 975.30 | 7.20% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | NOK 62.9B | NOK 927.34 | 0.73% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | NOK 51.1B | NOK 1,209.86 | 0.71% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | NOK 38.1B | NOK 278.11 | 2.40% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | NOK 72.3B | NOK 920.79 | 0.18% down | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | NOK 46.5B | NOK 826.03 | 2.08% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | NOK 96.2B | NOK 636.23 | 4.61% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | NOK 229.2B | NOK 199.89 | 0.78% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | NOK 270.6B | NOK 373.45 | 0.53% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | NOK 43.9B | NOK 401.23 | 1.59% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | NOK 73.7B | NOK 211.48 | 3.24% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | NOK 386.5B | NOK 672.21 | 0.92% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | NOK 477B | NOK 408.79 | 1.10% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | NOK 306.5B | NOK 497.01 | 1.38% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | NOK 82.9B | NOK 2,966.87 | 0.28% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | NOK 75.6B | NOK 449.82 | 2.05% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | NOK 659.5B | NOK 206.44 | 1.64% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | NOK 3.28T | NOK 1,332.26 | 4.19% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | NOK 79.7B | NOK 1,221.84 | 1.05% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | NOK 47B | NOK 489.44 | 1.24% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | NOK 57.9B | NOK 2,896.60 | 1.65% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | NOK 6.38T | NOK 2,651.13 | 1.92% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | NOK 153.6B | NOK 2,392.75 | 2.49% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | NOK 950.3B | NOK 9,186.27 | 1.11% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | NOK 11.94T | NOK 13,398.93 | 2.40% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | NOK 1.18T | NOK 579.30 | 2.64% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | NOK 61.2B | NOK 1,506.54 | 1.51% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | NOK 58.6B | NOK 897.27 | 0.61% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | NOK 172.2B | NOK 2,624.75 | 0.21% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | NOK 1.32T | NOK 5,209.73 | 0.55% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | NOK 4.89T | NOK 2,767.95 | 2.54% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | NOK 2.84T | NOK 1,503.10 | 2.61% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | NOK 239.1B | NOK 5,614.50 | 0.89% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | NOK 130.1B | NOK 260.36 | 3.85% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | NOK 147.1B | NOK 755.04 | 1.37% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | NOK 447.1B | NOK 3,914.38 | 2.34% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | NOK 1.55T | NOK 272.25 | 1.40% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | NOK 80.1B | NOK 1,155.21 | 2.14% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | NOK 115.4B | NOK 595.55 | 4.95% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | NOK 59.4B | NOK 420.34 | 0.81% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | NOK 946B | NOK 471.94 | 1.18% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | NOK 121.2B | NOK 145.40 | 1.36% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | NOK 2.69T | NOK 1,731.26 | 2.07% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | NOK 55.5B | NOK 81.61 | 2.49% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | NOK 1.1T | NOK 457.97 | 0.65% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | NOK 68.4B | NOK 1,300.88 | 1.34% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | NOK 72.1B | NOK 658.54 | 3.10% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | NOK 1.69T | NOK 382.51 | 3.10% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | NOK 1.76T | NOK 1,014.28 | 0.12% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | NOK 48.7B | NOK 582.89 | 0.43% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | NOK 69.3B | NOK 497.54 | 0.68% down | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | NOK 47.2B | NOK 271.03 | 0.34% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | NOK 90.6B | NOK 3,899.83 | 4.71% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | NOK 71B | NOK 811.04 | 1.86% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | NOK 337.8B | NOK 831.47 | 2.70% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | NOK 81.3B | NOK 101.69 | 1.73% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | NOK 255.5B | NOK 1,164.52 | 1.47% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | NOK 30.4B | NOK 156.92 | 0.43% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | NOK 44.9B | NOK 269.67 | 3.13% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | NOK 192.9B | NOK 1,440.54 | 5.09% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6987 NOK).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 19:53 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of NOK 49.06T as of 18 Nov 2026, 19:53 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.